My research centers health equity and explores the ethical and social dimensions of emerging biotechnologies.
One strand examines the ethical and social integration of technologies like gene therapy, precision medicine, and artificial blood into clinical care and everyday life, focusing on how patients, clinicians, and institutions navigate questions of cure, risk, access, and institutional readiness.
A second strand investigates the social and ethical dimensions of bodily transformation in the field of aesthetic medicine and synthetic biologics to understand concepts of enhancement, normalcy, and care. Across both strands, I use qualitative, quantitative, and computational methods to center patients' perspectives and surface the social forces that shape medical innovation.
I also collaborate on interdisciplinary projects related to health disparities and equity, including research on racial differences in suicide, medical mistrust, and public health promotion efforts.